Early sepsis decisions don’t just affect outcomes, they shape hospital capacity. In this clip, FMOL Health shares how improving early decision-making translated into the equivalent of an 85-bed hospital without new construction. From the Becker's Healthcare webinar, "SEP-1 Is Changing… Are You Prepared for What's Ahead in 2026?" — featuring Christopher Thomas, MD, Vice President & Chief Quality Officer, FMOL Health, and Chadd K. Kraus, DO, DrPH, FACEP, Vice Chair, Research – Department of Emergency and Hospital Medicine, Jefferson Health – Lehigh Valley. The conversation examines how sepsis-related decisions at the point of care ripple across throughput, capacity, and reimbursement — especially as Value-Based Purchasing raises the financial stakes. Watch the full webinar: https://lnkd.in/etamdJqa #SepsisCare #HospitalOperations #EmergencyMedicine
Cytovale
Biotechnology Research
South San Francisco, California 15,779 followers
At Cytovale, we’re focused on more rapid and insightful ways to diagnose fast-moving and immune-mediated diseases.
About us
Cytovale is a medical diagnostics company focused on providing a more rapid and insightful way to diagnose fast-moving and immune-mediated diseases. Our FDA cleared IntelliSep test is pioneering a new way of quickly and accurately analyzing white blood cells to stratify a patient’s risk of sepsis by performing a biomechanical evaluation of white blood cells collected from a standard blood draw in under 10 minutes. Cytovale’s first market application will be for sepsis, one of the fastest-moving, most lethal conditions in the world. Sepsis, a dysregulated immune response to infection, is often difficult to quickly and accurately diagnose. Sepsis is the no. 1 cause of death in hospitals, taking the lives of 270,000 people every year in the U.S. – more than opioid overdoses, prostate cancer, and breast cancer combined. Mortality from sepsis increases as much as eight percent with every hour of delayed treatment, and as much as 80 percent of sepsis deaths could be prevented with rapid diagnosis and treatment, making early detection essential. Cytovale aims to provide critical insight for early identification of patients at risk of having sepsis, in the time needed for it to be useful. Follow us on Twitter: twitter.com/cytovale
- Website
-
https://cytovale.com
External link for Cytovale
- Industry
- Biotechnology Research
- Company size
- 51-200 employees
- Headquarters
- South San Francisco, California
- Type
- Privately Held
- Founded
- 2013
- Specialties
- medical device
Locations
-
Primary
Get directions
2 Tower Pl
18th Floor
South San Francisco, California 94080, US
Employees at Cytovale
Updates
-
IntelliSep is now live at Froedtert Health Menomonee Falls Hospital! Serving over 24,000 emergency department patients annually, Menomonee Falls is the second facility in the Froedtert and Medical College of Wisconsin Health Network to bring IntelliSep into its ED — extending rapid sepsis risk assessment from the academic medical center to the community setting. The expansion follows strong real-world results at Froedtert Hospital, where a propensity-matched study of over 6,000 ED patients with suspected infection found IntelliSep use was associated with: ➡️ 42% reduction in mortality ➡️ ~2 fewer days in the hospital Read the study: https://lnkd.in/eD62z5Wr #Sepsis #EmergencyMedicine #IntelliSep Chanin McClurkin MSN, APRN, Nicola Staudinger MSN BSN RN CEN
-
-
Security is foundational to how we handle clinical data. Cytovale has achieved SOC 2 Type II attestation under the Security Trust Services Criteria supporting controls related to data security, availability, and confidentiality. Designed for critical clinical environments where trust and data protection are non-negotiable. Learn more: https://lnkd.in/e9wHe6PG #SOC2 #HealthcareIT #DataSecurity #Diagnostics
-
-
May 15 is Wear Blue day for National Critical Care Awareness & Recognition Month. If you're in the ICU we see the work behind those moments — the decisions made under pressure, the long shifts, the weight of caring for patients when the stakes are high. Cytovale is wearing blue today in recognition. #CritCareMonth #CriticalCare #Sepsis #EmergencyMedicine #Healthcare
-
-
Sepsis is time-sensitive, but early decisions in the ED don’t always get it right. In this clip, clinical leaders discuss how early diagnostic clarity can help avoid unnecessary antibiotic use in low-risk patients and improve decision-making at the point of triage. Excerpted from the Becker's Healthcare webinar, "SEP-1 Is Changing… Are You Prepared for What's Ahead in 2026?" — with Christopher Thomas, MD, Vice President & Chief Quality Officer, FMOL Health, and Chadd Kraus, DO, DrPH, FACEP, Vice Chair, Research – Department of Emergency and Hospital Medicine, Jefferson Health – Lehigh Valley. The full discussion covers how early decision-making in the ED — including emerging host-response approaches — is reshaping sepsis strategy as federal measurement and payment models evolve. Watch the full webinar: https://lnkd.in/ePHCK-Tw #SepsisCare #EmergencyMedicine #ClinicalDecisionMaking
-
Hospitals absorb the pressure of entire communities, and the teams behind them make it work under conditions most people never see. Behind that are teams navigating rising patient volumes, staffing constraints, and populations that grow more complex every year. The work that holds it all together rarely gets the visibility it deserves. During National Hospital Week, Cytovale recognizes the hospitals and care teams that show up and deliver every day. #HospitalWeek #HealthcareLeadership #Sepsis #EmergencyMedicine
-
-
Early sepsis decisions are time-sensitive, but that urgency can make accurate diagnosis more difficult. In this clip, clinical leaders discuss how time pressure in the ED can lead to over- or under-treatment, and why early decision-making is one of the hardest parts of sepsis care. This excerpt is from a Becker’s Healthcare webinar, “SEP-1 Is Changing… Are You Prepared for What’s Ahead in 2026?” Featuring: Christopher Thomas, MD, Vice President & Chief Quality Officer, Franciscan Missionaries of Our Lady Health System (FMOL Health) Chadd Kraus, DO, DrPH, FACEP, Vice Chair, Research - Department of Emergency and Hospital Medicine, Jefferson Health - Lehigh Valley The discussion explores how early clinical decisions in the ED shape diagnosis, treatment, throughput, and system-wide capacity under real-world constraints. Watch the full webinar: https://lnkd.in/eAh3uUqh #SepsisCare #EmergencyMedicine #HospitalOperations #ClinicalDecisionMaking
-
Maternal sepsis is a life-threatening emergency that can develop during pregnancy, childbirth, or the postpartum period — and it's one of the hardest to catch early. Pregnancy itself changes a patient's baseline physiology. Heart rate increases, white blood cell counts rise, respiratory rate shifts. These are normal changes, but they also happen to overlap with the early warning signs of sepsis. That makes recognition harder at exactly the moment it matters most. Globally, maternal sepsis contributes to at least 261,000 maternal deaths each year. Many are preventable with earlier recognition and timely treatment. During Maternal Sepsis Week, Cytovale is committed to raising awareness about the diagnostic challenges that make this condition so dangerous — and the importance of giving clinicians better tools to identify it sooner. Learn more: https://lnkd.in/eg5z_kwV #MaternalHealth #Sepsis #PatientSafety #WomensHealth
-
-
Sepsis protocols have evolved dramatically over the past decade. But many frontline clinicians are still working with diagnostic tools that haven’t kept pace with today’s emergency care demands. In a new MedPage Today KevinMD article, Jasjot S. Johar, MD, of Banner Health, explores a growing challenge in the ED: clinicians are expected to act quickly, often without the diagnostic clarity they need. When sepsis is suspected, the safest move is often to treat aggressively. But that approach can lead to over-testing, over-treatment, missed alternative diagnoses, and added strain on already stretched ED resources. The article explores: • Why early sepsis recognition remains difficult in the ED • The risk of putting patients on the wrong clinical pathway • Why current diagnostics detect infection or inflammation, but not the underlying immune response • How approaches that assess the patient’s immune response may support earlier, more informed risk stratification As emergency medicine continues to evolve, improving diagnostic clarity earlier in the patient journey will be critical to aligning care decisions with true patient need. 🔗 Read the full perspective: https://lnkd.in/eRR6qPM6 #EmergencyMedicine #SepsisRisk #ClinicalInnovation #HospitalLeadership #ClinicalDiagnostics #HostResponse #Cytovale
-
-
Nurses are often the first to recognize when something isn't right. A subtle change in vitals. A shift in how a patient looks or responds. The moment something feels off — before the data catches up. That clinical instinct is built through experience, presence, and the kind of attention that doesn't clock out. This week, Cytovale recognizes the nurses who carry that awareness into every patient interaction and the quiet, critical impact of their judgment. Thank you. #NursesWeek #ThankYouNurses #Sepsis #EmergencyCare
-